*ST恆康(002219.SZ):控股股東與深圳海王集團等簽署協議書
格隆匯 2 月 9日丨*ST恆康(002219.SZ)公佈,公司於2021年2月9日接到公司控股股東闕文彬通知,獲悉闕文彬與北京新里程健康產業集團有限公司、深圳海王集團股份有限公司、五礦金通股權投資基金管理有限公司共同簽署了《協議書》。
甲方:北京新里程健康產業集團有限公司;乙方:深圳海王集團股份有限公司;丙方:闕文彬;丁方:五礦金通股權投資基金管理有限公司;
為推進恆康醫療破產重整工作,經四方友好協商,達成如下協議:
1、四方認同由甲方、甲方關聯方及其指定的聯合投資人(“甲方”)作為恆康醫療破產重整產業投資人,通過認購恆康醫療資本公積轉增股本的方式獲得上市公司股份和控制權。甲方作為產業投資人,發揮其雄厚的產業資源優勢,着力提升恆康醫療核心競爭力。各方發揮各自優勢,共同推進上市公司重整工作。
2、乙方、丙方、丁方一致同意,終止三方於2020年11月30日簽署的《深圳海王集團股份有限公司與闕文彬及五礦金通股權投資基金管理有限公司之重整投資合作框架協議》。自本協議簽署之日起,《重整投資合作框架協議》中約定的各方權利、義務均終止。
3、本協議自四方簽署之日起生效,未盡事宜另行協商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.